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Background andAim:Hormone therapy (HT) has long been thought beneficial for control-
ling menopausal symptoms and human cognition. Studies have suggested that HT has a
positive association with working memory, but no consistent relationship between HT and
neural activity has been shown in any cognitive domain.The purpose of this meta-analysis
was to assess the convergence of findings from published randomized control trials studies
that examined brain activation changes in postmenopausal women.
Methods:A systematic search for fMRI studies of neural responses during working mem-
ory tasks in postmenopausal women was performed. Studies were excluded if they were
not treatment studies and did not contain placebo or blank controls. For the purpose of the
meta-analysis, 8 studies were identified, with 103 postmenopausal women taking HT and
109 controls.
Results: Compared with controls, postmenopausal women who took HT increased acti-
vation in the left frontal lobe, including superior frontal gyrus (BA 8), right middle frontal
gyrus (BA 9), anterior lobe, paracentral lobule (BA 7), limbic lobe, and anterior cingulate (BA
32). Additionally, decreased activation is noted in the right limbic lobe, including parahip-
pocampal gyrus (BA 28), left parietal lobe, and superior parietal lobule (BA 7). All regions
were significant at p≤0.05 with correction for multiple comparisons.
Conclusion:Hormone treatment is associated with BOLD signal activation in key anatomi-
cal areas during fMRI working memory tasks in healthy hormone-treated postmenopausal
women. A positive correlation between activation and task performance suggests that
hormone use may benefit working memory.
Keywords: hormone therapy,ALEmeta-analysis, functionalmagnetic resonance imaging, postmenopause,working
memory, neural activation
INTRODUCTION
The influence of hormone treatment (HT) on brain and cognition
in postmenopausal women has been a controversial topic. Cross-
sectional studies and meta-analyses have promoted the idea that
HT might enhance verbal memory performance and decrease the
risk for developing dementia in postmenopausal women (Barrett-
Connor and Stuenkel, 2001; LeBlanc et al., 2001; Maki, 2006).
Studies indicated that HT users were better protected against cog-
nitive decline and dementia and may have better performance
during working memory tasks than non-users (Hogervorst et al.,
2009; Davis et al., 2013). Similarly, a follow-up study of women
who began hormone use around menopause detected lower cog-
nitive impairment (Bagger et al., 2005). In a memory study, early
initiators of HT performed better than late initiators in working
memory tasks, including attention, concentration, and mental sta-
tus (MacLennan et al., 2006). These studies thus suggest that HT
may have beneficial effects on the central nervous system. How-
ever, other studies pointed out that HT has no detrimental effect on
cognitive performance in early postmenopausal women (Davison
et al., 2013). Later HTs have no preventive effect on AD and MCI
in postmenopausal women (Maki, 2005; Sherwin, 2005). While
most women receiving estrogen plus progestin did not experi-
ence clinically relevant adverse effects on cognition compared with
placebo, a small increased risk of clinically meaningful cognitive
decline occurred in the estrogen plus progestin group (Espeland
et al., 2010). There are no adverse or beneficial effects of HT on
cognitive function in younger postmenopausal women (Brown,
2013). Similarly, large controlled studies have suggested that HT
has no beneficial effects on maintaining cognition (Henderson
et al., 2000; Mulnard et al., 2000; Wang et al., 2000; Resnick et al.,
2006). Moreover, data from the only large randomized controlled
trial published to date, the Women’s Health Initiative Memory
Study, did not confirm these observations and have even suggested
an increase in dementia risk for women using hormonal replace-
ment therapy compared to controls (Ryan et al., 2008). Based on
currently available data, routine therapeutic use of estrogens in
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women with AD is not justified (Markou et al., 2005) and should
not be used for dementia prevention (NIA, 2004). Thus the effect
of HT on working memory remains unclear based on the results
of studies involving direct manipulations of estradiol level.
Inconsistencies in estradiol effects are also observed in struc-
tural and functional brain imaging studies. Increases or decreases
in activation are often not accompanied by changes in task per-
formance, leading Maki and Resnick (Maki et al., 2011) suggest
that brain imaging may be more sensitive to effects of estradiol
or other hormones than task performance. Evidence from animal
models has found estrogen receptors in numerous sites throughout
the brain including the hippocampus, amygdala, hypothalamus,
brainstem, and cerebral cortex suggesting that estrogen therapy
may impact cognitive functioning through potential affects on
these brain areas (Brake et al., 2001). It was also shown that estro-
gens enhance basal forebrain, hippocampus, and cortex choliner-
gic activity by influencing the synthetic enzyme for acetylcholine
as well as by increasing the number of cholinergic neurons (Smith
et al., 2001). Further, estrogen has been suggested to modulate
various neurotransmitters (Moses et al., 2000; Smith et al., 2001),
increase cerebral blood flow (Greene, 2000; Slopien et al., 2003),
regulate the formation of synapses, affect neuronal survival (Nilsen
et al., 2000; Gleason et al., 2005), influence the expression of
APOE, and provide neuroprotective effects, all of which may either
directly or indirectly impact cognitive functioning (Slopien et al.,
2003). The fMRI results demonstrate that HT, relative to placebo,
increased the response of the striatum and ventromedial pre-
frontal cortex, two areas that have been shown to be, respectively,
involved during reward anticipation and at the time of reward
delivery. Using both visual and verbal working memory tasks, one
fMRI study found increased activation bilaterally in the superior
frontal gyrus and in the inferior parietal lobule in subjects who
were receiving high-dose conjugated equine estrogen compared
with controls, while decreases in inferior parietal, which activa-
tion for storage of non-verbal material (Shaywitz et al., 1999), have
also been reported. Areas of activation were deemed significantly
different in the prior findings.
Although prior studies have examined the effects of HT on
working memory task performance in healthy postmenopause
women, to our knowledge, no brain imaging meta-analysis exam-
ined the brain activation differences in postmenopausal women.
Our study assessed the convergence of findings from published
randomized control trials studies that examined brain activation
changes in postmenopausal women. A meta-analysis employing
the activation likelihood estimate (ALE) method was performed
to locate anatomical regions with significant activation differences.
The ALE method permits the creation of three-dimensional (3D)
probability maps that show the brain regions that are most likely to
demonstrate morphometric differences between HT and controls.
The frontal lobes are of paramount significance in determining
emotions and judgments related to sympathy, which is defined as
the ability to perform daily activities, personality manifestations,
and decisions (Badre et al., 2009; Tiemeier et al., 2010). Base on
the exiting studies (Shaywitz et al., 1999; Greene, 2000; Moses
et al., 2000; Nilsen et al., 2000; Brake et al., 2001; Smith et al.,
2001; Slopien et al., 2003; Gleason et al., 2005), we hypothesize
that postmenopausal women who took HT would show increased
activation in the frontal lobe, including temporal lobe and the
anterior cingulate, brain regions known to be involved in cognition
and working memory.
METHODS
DATA SOURCES AND INCLUSION CRITERIA
A systematic search strategy was performed to identify the rel-
evant studies. We searched PubMed, MEDLINE, and EMBASE
from 1993 to 2014 for all relevant published observational stud-
ies and clinical trials. The following key terms were employed:
“HT,” “HRT,” “HT,” “ERT,” “functional MRI or fMRI,” “cognitive
dysfunction,” “postmenopausal,” “brain activation,” and “work-
ing memory.” The reference lists of these articles were searched
to obtain additional relevant studies. All identified articles were
reviewed by at least two authors, and studies were included in the
meta-analysis based on a consensus decision (see Figure 1).
To meet the inclusion criteria, the studies had to (a)
report group comparisons between postmenopausal women who
received HT and matched controls, (b) employ fMRI, (c) report
their results in a standard stereotactic space (either Talairach or
Montreal Neurological Institute space), and (d) investigate work-
ing memory or working memory-related tasks. Studies that did
not fulfill these requirements were excluded. Treatment, gender,
and age were not restricted and the HT brain activation studies
did not include a control.
The data extracted from each study included: a description
of (a) each memory task and (b) foci of task-related activation
changes in which the active and control states were different
between the HT group and the control as well as (c) clinical data
concerning hormone dose, years of estrogen use, and the age-
matching of the control group. This study examined all foci that
were reported as significant based on the above criteria designated
in the included studies.
ALE META-ANALYSIS PROCEDURE
Two separate ALE meta-analyses were performed: one on fMRI
studies reporting that brain activation was increased in post-
menopausal women receiving HT compared to controls and a
second on studies reporting that brain activation was decreased.
The meta-analyses were performed using GingerALE software,
version 2.1.1 (Laird et al., 2005)1. The main idea behind ALE
is to treat the reported foci as centers for 3D Gaussian proba-
bility distributions to capture the spatial uncertainty associated
with each focus. Foci reported for any given study were then
combined to a modeled activation (MA) map. The reported
foci in the original studies in MNI space were transformed
into Talairach space using the tal2icbm algorithm. All ALE data
processing was performed using Brain Map Search and View
software2. Statistical significance was assessed using an analyt-
ical equation. The assumption is reasonable for data imaging,
based on an assumption of positive dependence (Genovese et al.,
2002), and the false discovery rate (FDR) was set at 0.05 to
correct the p-threshold for multiple comparisons (Laird et al.,
2005). Each ALE map was overlaid onto an anatomical template
1http://brainmap.org/ale
2http://brainmap.org
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FIGURE 1 | Diagram of studies included in the present meta-analysis.
generated by spatially normalizing the International Consor-
tium for Brain Mapping (ICBM) template to the Talairach space
(Kochunov et al., 2002). The resulting regions were anatomically
labeled by reference to probabilistic cytoarchitectonic maps of the
human brain.
RESULTS
NUMBER OF STUDIES FOUND
The literature contained eight studies in which the effect of HT
was investigated in working memory. In total, the meta-analysis
was conducted on 103 postmenopausal women taking HT and
109 controls (see Table 1). These studies include all relevant treat-
ment studies through 2014. Studies were excluded if they did not
perform working memory tasks, or included a combination of
estrogen and testosterone, or did not include a control group, or
included women suffering from cognitive impairment.
CHANGES IN NEURAL ACTIVATION TO WORKING MEMORY TASKS
We performed two ALE analyses to investigate and aggregate the
known data that exist regarding the effects of HT on neural activ-
ity in postmenopausal women during working memory tasks. The
first analysis pooled the results of an increase in neural activation
(8 experiments, 73 foci), and the second analysis pooled the results
of a decrease in brain activation (3 experiments, 18 foci) (p≤ 0.05
FDR-corrected; see Table 2; Figure 2).
In the first meta-analysis, five clusters of increased task-related
activity after HT were found in the left frontal lobe, superior frontal
gyrus (BA 8), middle frontal gyrus (BA 9), parietal lobe, pre-
cuneus (BA 7), paracentral lobule (BA 5), limbic lobe, and anterior
cingulate (BA 32) (p< 0.01 FDR-corrected, k > 100; see Figure 3).
Several clusters of decreased activation after HT were detected
in the second ALE analysis. Clusters of decreased activation were
located in the right limbic lobe, parahippocampal gyrus (BA 28),
left parietal lobe, and superior parietal lobule (BA 7) (p≤ 0.05
FDR-corrected; see Table 2; Figure 4).
HT AND PERFORMANCE OF WORKING MEMORY
Four papers measured the relationship between HT and perfor-
mance on verbal memory task. Two studies indicated that HT use
increases frontal lobe activity during verbal memory tasks, but
the degree of this increase is related to cognitive load (Dumas
et al., 2010). One study demonstrated that HT results in changes
in neural activation in verbal memory circuits in postmenopausal
women and suggests that estrogen may enhance the overall effi-
ciency of verbal memory processes in postmenopausal women
(Persad et al., 2009). Another study suggested that HT selectively
enhances verbal perseveration and is an important component of
executive function by increasing activation in the inferior frontal,
dorsolateral prefrontal, and posterior parietal regions (Joffe et al.,
2006). One study indicated that no significant differences in visual
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FIGURE 2 | ALE map of the postmenopausal women during working memory. Decreased (green) and increased (red) activity following HT compared with
the controls (p<0.01; FDR-corrected; k >100).
FIGURE 3 | An ALE map presenting the increased activity in postmenopausal women undergoing HT during working memory tasks compared with
the controls (p< 0.01; FDR-corrected; k >100).
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Table 1 | Publications included in the meta-analysis, the tasks they employed, the number of subjects who were investigated, and the mean age
of the women and their estrogen dose for the ALE meta-analysis.
Study Women in HT
group/control
Field strength
(T)
Task Mean age
(SD)
Years of
estrogen use
Estrogen dose
Dumas et al.
(2010)
10/10 3 Verbal N -back
sequential letter
59.1 (5.5) 7.0 (6.8) 1 mg oral 17-β estradiol
Dumas et al.
(2012)
12/12 3 Verbal N -back
sequential letter
59.1 (5.5) 7.01 (6.8) 1 mg oral 17-β estradiol
Smith et al.
(2006)
5/5 3 Visual working
memory
56.9 (1.4) 0.17 5µg ethinyl estradiol and
1 mg norethindrone acetate
Stevens et al.
(2005)
8/8 1.5 Visual oddball 76.9 (3.9) 0.5 Ultralow dose estrogen
(0.25 mg/day)
Persad et al.
(2009)
5/5 3 Verbal memory No mention 0.17 5 ugethinyl estradiol and
1 mg norethindrone acetate
Maki et al. (2011) 17/17 3 Verbal memory 60.16 (2.88) >2 –
Joffe et al. (2006) 26/24 1.5 Verbal memory 50.0 (3.4) 0.25 17A-estradiol 0.05 mg/day
patch
Berent-Spillson
et al. (2010)
20/28 3 Visual working
memory
64.4 (4.8) 13.3 Estrogens 0.625 mg/day
Table 2 | Results from the ALE meta-analysis of treatment effects on studies in postmenopausal women (p<0.05, FDR-corrected).
Location BA Peak activation Volume (mm3) ALE value×10−3
x y z
(A) AREAS OF INCREASEDACTIVATION FOLLOWING HT
Left cerebrum, frontal lobe, superior
frontal gyrus
8 −10 46 36 416 14.50
Middle frontal gyrus 9 −38 18 34 368 13.08
Right cerebrum, superior frontal
gyrus
9 16 50 34 256 10.67
Anterior lobe, culmen – 0 −52 6 200 10.10
Parietal lobe, precuneus 7 0 −46 54 144 9.93
Right cerebrum, anterior cingulate 32 4 46 −2 112 9.86
Paracentral lobule 5 −2 −44 58 – 9.78
(B) AREAS OF DECREASEDACTIVATION FOLLOWING HT
Right cerebrum, limbic lobe,
parahippocampal gyrus
28 14 −6 −12 296 9.93
Left cerebrum, parietal lobe,
superior parietal lobule
7 −18 −72 57 280 10.36
Results are shown in Talairach coordinates. Significance threshold is p<FDR 0.01 and k>100.
task performance were found in response to HT. However, there
was evidence that the HT group had both reductions and increases
in the amplitude of hemodynamic response in some regions,
including the occipital and parietal lobes, motor cortex, anterior
cingulate, and PFC (Stevens et al., 2005).
SUB-ANALYSES FOR ESTROGEN LONG-TERM USE AND
SHORT-TERM USE
In further sub-analysis, we investigated the effects of estro-
gen experience. The brain network supporting long experience
[usually more than 2 years (Barrett-Connor and Stuenkel,
2001)] estrogen use (27 Foci, 4 Experiments) included clus-
ter of activity in the left limbic lobe, right frontal lobe, and
left anterior lobe. Short experience [usually <2 years (Barrett-
Connor and Stuenkel, 2001)] included clusters of activity in
the right front lobe, left front lobe, limbic lobe, and pari-
etal lobe. We get similar behavioral outcomes after exclud-
ing short-term estrogen use. This suggests that long-term hor-
mone use have a persisting chronic effect in postmenopausal
women.
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FIGURE 4 | An ALE map presenting the decreased activity in postmenopausal women undergoing HT during working memory tasks compared with
the controls (p< 0.01; FDR-corrected; k >100).
DISCUSSION
Historically, cognitive benefits of postmenopausal hormone ther-
apy (HT) have not been consistently demonstrated and the brain
activation patterns are inconsistent. In this study, we addressed the
cognitive effects of hormones in women and performed an ALE
meta-analysis on functional brain imaging studies to investigate
and aggregate the known data that exist regarding the effects of
HT on neural activity in postmenopausal women during working
memory tasks. Our results indicate that hormone use is asso-
ciated with increased regional brain activation during working
memory task, with women in hormone-treatment groups exhibit-
ing a more robust neural response than placebo-treated women.
Women receiving HT exhibited increases in brain activation in the
frontal lobe and the anterior cingulate cortex (ACC) (see Table 2;
Figure 3), a region where decreased activity can be predictive of
Alzheimer’s disease (Rasgon et al., 2005). This finding suggests
that HT may enhance brain function. The frontal lobe and the
ACC may be important for processing lexical information and for
the associated cognition and decision-making (Bush et al., 2000).
This supports our prior hypothesis that HT maintains a positive
effect on working memory processes.
Activation in the frontal lobes has been identified in post-
menopausal women after estradiol treatment (Dumas et al., 2010).
The frontal lobes are of paramount significance in determining
emotions and judgments related to sympathy, which is defined
as the ability to perform daily activities, personality manifesta-
tions, and decisions (Badre et al., 2009; Tiemeier et al., 2010). The
hormone effects on working memory tasks may occur through
an effect on the frontal lobe. Activation of frontal regions during
memory tasks has been associated with the active maintenance
of information (Cohen et al., 1997). Activation in frontal regions
during a working memory task has been related to improved per-
formance in older subjects (Davis et al., 2008). Hormones exert
a greater modulatory effect on the function of the frontal lobe
when working memory load is increased (Dumas et al., 2010),
and episodic memory tasks are associated with the frontal lobe
(Tulving et al., 1994). fMRI–BOLD signal in the frontal lobes,
a region central to memory processing, positively correlated to
task accuracy, implying a cognitive benefit to the increased activ-
ity measured during the memory task (Joffe et al., 2006; Dumas
et al., 2010).
Similarly, across our ALE meta-analyses, we found that, after
HT, postmenopausal women exhibited greater activity in the ACC
than controls. The ACC plays an important role in integrating cog-
nitive and emotional processes to support goal-directed behavior
(Krause-Utz et al., 2014). On the other hand, ACC is involved
in rational cognitive functions, including reward anticipation,
impulse control decision-making, empathy (Bush et al., 2000),
and emotion (Decety and Jackson, 2004; Jackson et al., 2006). This
finding in the present study is consistent with the effect of HT on
the emotion-processing circuitry in postmenopausal women (Frey
et al., 2010; Shafir et al., 2012). However, another study revealed
contradictory results in which the BOLD responses were reduced
in the dorsolateral PFC and the dorsal anterior cingulate of the HT
group compared with the control group during a negative emo-
tion task. These differences between the HT and control groups
may reflect a recovery of emotional responsiveness in these older
women following HT (Love et al., 2010).
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Additionally, decreased activation in the parahippocampal
gyrus (BA 28), including left parietal lobe and superior pari-
etal lobule (BA 7) (see Table 2; Figure 4), was observed in the
HT group. Importantly, these regions may also support cogni-
tive functions, including verbal memory (Zec and Trivedi, 2002;
Sherwin, 2012). The parahippocampal gyrus is a gray matter
cortical region of the brain that surrounds the hippocampus.
The key role of this region is memory encoding and retrieval.
Abnormalities may indicate underlying conditions, such as schiz-
ophrenia, Alzheimer’s disease, and hippocampal sclerosis (Ferreira
et al., 2003). The observation of hyper-activation in the parahip-
pocampal gyrus is consistent with the finding of Dr Maki leading
investigators that women receiving HT exhibit decreased regional
cerebral blood flow in the right precuneus, the dorsal frontal
gyrus, and the parahippocampal gyrus during a verbal mem-
ory task (Resnick et al., 1998). Their later study suggested that
deactivation in the left parahippocampal gyrus relates to better
verbal memory performance, and this effect was specific to the
verbal recognition condition (Maki et al., 2011). Another study
found sustained decreases in activation in bilateral regions of
parahippocampal cortex, suggesting that the parahippocampal
gyrus might become deactivated when participants entered into
a sustained state of retrieval during recognition tasks (Donaldson
et al., 2001). Together, the findings of decreased parahippocam-
pal activation in perimenopausal HT users suggest that peri-
menopausal HT enhances both state-dependent and recollective
processes contributing to verbal recognition performance.
Sub-analyses for estrogen long-term and short-term use
revealed almost the same results to the main results of HT group.
The goal of this study was to evaluate differences in working mem-
ory after hormone use compared to placebo use, so women who
recently quit long-term hormones were included along with cur-
rent hormone users. Apart from a statistically significant difference
in mean years of education, these two groups were demograph-
ically similar (although the smaller sample size used to compare
current and past users may increase the likelihood of a type II
error). After accounting for variations in age, education, and age
at hormone initiation, long-term users did not have more acti-
vation than short-tem users in any part of the brain. Long-term
users showed slightly more activation than short-term users in
only one small region within the prefrontal cortex. While it is dif-
ficult to make conclusions based on one differing region, these
results may be consistent with others that have indicated a per-
sisting cognitive benefit to past hormone users (Hogervorst et al.,
2009). Other than this region, the activation patterns between
these two HT groups were sufficiently similar to justify including
them in the same groups when comparing hormone ever-users to
placebo-users.
This study has some limitations. First, methodological limita-
tions led to a small number of available studies, and the sample
sizes are small. Second, trials recruit women who may not be rep-
resentative of the general population. Third, differences among
the studies in the education, general health, motivation level, and
age. These differences raise the possibility that the controls and
HT groups may differ with respect to characteristics that could
influence brain function. We consider this limitation unavoid-
able. Third, many trials are too short to evaluate long-term effect
of HT. However, such trials provide more highly reliable evi-
dence of the effectiveness of a treatment than observational studies
(Miller and Kearney, 2004). Fourth, the functional imaging studies
included employed different working memory tasks and the years
of estrogen use are various, which could result in a source of het-
erogeneity. Fifth, the estrogen dose of HT was not identical across
the included studies, which may influence the effect of estrogen
on postmenopausal women.
CONCLUSION
In summary, the present study demonstrated that women who
received HT exhibited increases in brain activation in the frontal
lobe and ACC. In addition, decreased activation in the parahip-
pocampal gyrus (BA 28), left parietal lobe, and superior parietal
lobule (BA 7) were detected. The results are consistent with
our hypothesis. Together, the findings of enhanced frontal lobe
activation and decreased parahippocampal activation in peri-
menopausal HT users suggest that HT enhances both state-
dependent and recollective processes contributing to cognitive
performance.
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